Akums Drugs and Pharmaceuticals Past Earnings Performance
Past criteria checks 3/6
Akums Drugs and Pharmaceuticals has been growing earnings at an average annual rate of 36.2%, while the Life Sciences industry saw earnings growing at 25.2% annually. Revenues have been growing at an average rate of 2.4% per year. Akums Drugs and Pharmaceuticals's return on equity is 10%, and it has net margins of 6.8%.
Key information
36.2%
Earnings growth rate
36.1%
EPS growth rate
| Life Sciences Industry Growth | 11.2% |
| Revenue growth rate | 2.4% |
| Return on equity | 10.0% |
| Net Margin | 6.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Akums Drugs and Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 40,827 | 2,778 | 7,277 | 0 |
| 30 Jun 24 | 42,309 | 2,444 | 7,115 | 0 |
| 31 Mar 24 | 41,817 | -40 | 6,918 | 0 |
| 31 Dec 23 | 40,846 | -671 | 6,737 | 0 |
| 30 Sep 23 | 39,875 | -1,302 | 6,555 | 0 |
| 30 Jun 23 | 37,158 | -1,277 | 6,258 | 0 |
| 31 Mar 23 | 36,572 | 949 | 6,291 | 0 |
| 31 Mar 22 | 36,752 | -2,525 | 5,399 | 0 |
| 31 Mar 21 | 27,262 | 1,227 | 4,541 | 0 |
Quality Earnings: 544222 has high quality earnings.
Growing Profit Margin: 544222 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 544222's earnings have grown significantly by 36.2% per year over the past 5 years.
Accelerating Growth: 544222 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 544222 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Life Sciences industry (37.9%).
Return on Equity
High ROE: 544222's Return on Equity (10%) is considered low.